Patient: 18F, 52 kg | Proposed dose: 200 mg/day (3.85 mg/kg/day) | Duration: 6–9 months
Indication: Positive antiphospholipid antibodies (aCL IgG 40, β2GP1 IgG 80), microvascular changes on nailfold capillaroscopy, UCTD-like multisystem presentation with post-viral onset